Michael McMullen - Agilent Technologies CEO

A -- USA Stock  

Earnings Call  This Week

  CEO
Mr. Michael R. McMuller is President, Chief Executive Officer, Director of Agilent Technologies, Inc. Mr. McMullen has served as our Chief Executive Officer since March 2015 and as President since September 2014. From September 2014 to March 2015 he also served as our Chief Operating Officer. From September 2009 to September 2014 he served as Senior Vice President, Agilent and President, Chemical Analysis Group. Prior to that, he served in various capacities for Agilent including as our Vice President and General Manager of the Chemical Analysis Solutions Unit of the Life Sciences and Chemical Analysis Group and as Country Manager for our China, Japan and Korea Life Sciences and Chemical Analysis Group. Prior to that, Mr. McMullen served as the Controller for the HewlettPackard Company and Yokogawa Electric Joint Venture from July 1996 to March 1999. Since September 2018, Mr. McMullen has served as a member of the Board of Directors of Coherent, Inc. r. McMullen has broad and deep experience with the company and its businesses having been an employee of the company and its predecessor, HewlettPackard, for over 20 years. During the course of his career, he has developed considerable expertise in, and indepth knowledge of, our businesses from the perspective of an individual contributor and at numerous levels of management. This perspective gives valuable insight to our board.
Age: 56  CEO Since 2015      
408-345-8886  http://www.agilent.com

Michael McMullen Latest Insider Activity

Management Efficiency

The company has return on total asset of 0.09 % which means that for every 100 dollars spent on asset it generated profit of $0.09. This is way below average. Similarly, it shows return on equity (ROE) of 0.17 % implying that it made 0.17 on every $100 invested by shareholders.
The company has accumulated 1.8 B in total debt with debt to equity ratio (D/E) of 37.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 2.09 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Found 13 records

CEO Since

Christopher LinthwaiteFluidigm Corporation
2016
Gajus WorthingtonFluidigm Corporation
2016
Kevin SayerDexCom
2018
Deborah TannerLaboratory Corporation Of Ameri
2015
Yue DengGlobal Cord Blood Corporation
N/A
Stephen LinthwaiteFluidigm Corporation
2016
James BoyleLaboratory Corporation Of Ameri
N/A
Gary HuffLaboratory Corporation Of Ameri
2017
John RatliffLaboratory Corporation Of Ameri
2019
Paul KirchgraberLaboratory Corporation Of Ameri
2019
Adam SchechterLaboratory Corporation Of Ameri
2019
Rui ArashiyamaGlobal Cord Blood Corporation
N/A
Helmy EltoukhyGuardant Health
2017

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Medical Laboratories Research classification in USA and is traded on BATS Exchange. It employs 15700 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Boulevard and employs 15,700 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President, Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President, Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Chairman of the Board
Robert Herbold, Independent Director

Stock Performance Indicators

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Search macroaxis.com